Immunicom


Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunothera... Read more

Industries

Employees

11-50

Links


Org chart

Amir Jafri
CEO & Founder
Collapse
Dave L. Lopez
General Counsel
Steve Prince
Chief Commercial Officer
Steven Josephs
Chief Scientist
Julie Tubbs
VP, Molecular Production
Kamel Djazouli
VP, Global Medical Affairs

Board & advisors



Offices